Cardiovascular System Practice Questions

Q: Which of the following conditions can lead to a decrease in afterload?

Severe anemia. ***Severe anemia*** - In **severe anemia**, the **blood viscosity** is reduced, and the body compensates by decreasing systemic vascular resistance to maintain tissue perfusion, thereby lowering **afterload**. - The reduced **oxygen-carrying capacity** triggers vasodilation to maximize blood flow to tissues, contributing to decreased afterload. - This represents a **chronic compensatory mechanism** that results in sustained reduction of afterload. *Hypothyroidism* - **Hypothyroidism** typically leads to an **increase in systemic vascular resistance** and thus can increase afterload. - It often results in **bradycardia** and reduced cardiac output, which can further elevate afterload to maintain pressure. *Increased physical activity* - During **physical activity**, there is **vasodilation in exercising muscles**, which acutely decreases systemic vascular resistance. - However, this is accompanied by **increased cardiac output** and **elevated blood pressure** due to sympathetic stimulation, and the afterload reduction is **transient** rather than sustained. - In the context of this question asking about conditions that lead to decreased afterload, **severe anemia** is the better answer as it represents a chronic pathological state with sustained afterload reduction, whereas exercise represents a temporary physiological response. *None of the options* - This option is incorrect because **severe anemia** is a recognized cause of decreased afterload.

Q: What is the primary role of ion channels in the vascular endothelium?

Potassium ion regulation in endothelial cells. ***Potassium ion regulation in endothelial cells*** - **Potassium channels**, particularly **KCa3.1 (IKCa)** and **KCa2.3 (SKCa)**, are the **primary ion channels** in vascular endothelium - They maintain the **endothelial membrane potential** at hyperpolarized levels (around -40 to -70 mV) - This hyperpolarization **enhances eNOS activity**, promoting **nitric oxide (NO) release** and **vasodilation** - Potassium channels are thus critical regulators of **vascular tone** and **endothelial-dependent relaxation** *Calcium ion regulation in endothelial cells* - While **calcium ions** are essential for endothelial signaling and triggering NO release, calcium channels serve more as **secondary messengers** rather than primary regulators - **Calcium influx** (via TRP channels, store-operated channels) typically **activates** the potassium channels, which then provide the primary regulatory control - Calcium acts as a **trigger**, while potassium channels provide **sustained regulation** of membrane potential *Chloride ion regulation in endothelial cells* - **Chloride channels** are involved in **cell volume regulation** and may modulate membrane potential - Their role in endothelial cells is **less well-characterized** and not considered the primary mechanism for regulating vascular tone - They play more supportive rather than primary regulatory roles in endothelial function *Sodium ion regulation in endothelial cells* - **Sodium channels** are crucial in **excitable cells** (neurons, muscle) for action potential generation - In **non-excitable endothelial cells**, sodium transport is important for cellular homeostasis but does not constitute the **primary ion channel regulatory mechanism** for vascular function - Endothelial cells rely primarily on potassium channels for membrane potential regulation rather than sodium channels

Q: During the sympathetic fight-or-flight response, what is the primary cardiovascular effect of epinephrine and norepinephrine on skeletal muscle vasculature?

Increased blood flow to muscles. ***Increased blood flow to muscles*** - **Epinephrine** and **norepinephrine** cause **vasodilation** in skeletal muscle arterioles, shunting blood toward tissues critical for immediate physical action. - This response ensures that muscles have adequate **oxygen** and **nutrients** to support intense activity, enabling a quick escape or confrontation. *Increased blood flow to the skin* - During fight-or-flight, the body prioritizes essential organs, causing **vasoconstriction** in the skin to redirect blood flow away from non-essential areas. - This redirection helps to conserve blood and reduce potential blood loss from surface injuries. *Bronchoconstriction* - **Epinephrine** and **norepinephrine** actually cause **bronchodilation**, leading to the relaxation of airway smooth muscles. - This effect increases the diameter of the airways, allowing more air to enter and exit the lungs, thereby enhancing **oxygen intake** and carbon dioxide expulsion. *Decreased heart rate* - The primary effect of **epinephrine** and **norepinephrine** is to **increase heart rate** and myocardial contractility. - This cardiac acceleration enhances **cardiac output**, ensuring rapid and efficient delivery of oxygenated blood throughout the body to meet the demands of stress.

Q: Aortic valve closure occurs in which part of cardiac cycle?

Beginning of isovolumetric relaxation. ***Beginning of isovolumetric relaxation*** - Aortic valve closure marks the end of **ventricular systole** and the start of **isovolumetric relaxation**, as blood ceases to be ejected and the ventricle begins to relax while remaining closed. - This event corresponds to the **second heart sound (S2)** and signifies the beginning of a period where ventricular volume remains constant, but pressure drops. *Beginning of isovolumetric contraction* - This phase begins with the closure of the **mitral and tricuspid valves** (first heart sound, S1), as ventricular pressure rises but volume remains constant before ejection. - The aortic valve is still closed at this point, as ventricular pressure is not yet high enough to open it. *Beginning of ventricular ejection* - This phase begins when the **aortic valve opens** as ventricular pressure exceeds aortic pressure, allowing blood to be ejected from the left ventricle. - Aortic valve closure occurs *after* ejection, not at its beginning. *During rapid ventricular filling* - Rapid ventricular filling occurs when the **mitral valve opens** (following isovolumetric relaxation), allowing blood to flow from the atria into the ventricles. - During this phase, the aortic valve is closed, but its closure happened earlier, at the beginning of isovolumetric relaxation.

Q: Which of the following factors is most commonly targeted therapeutically for blood pressure control?

Peripheral resistance. ***Peripheral resistance*** - **Peripheral resistance** is primarily determined by the **arteriolar tone**, which can be effectively modulated by various antihypertensive medications. - Medications like **ACE inhibitors**, **ARBs**, **calcium channel blockers**, and **diuretics** all influence peripheral resistance to lower blood pressure. *Heart rate* - While heart rate contributes to **cardiac output** and thus blood pressure, it is not the most common primary target for hypertension management. - **Beta-blockers** reduce heart rate, but they are often used for specific indications beyond essential hypertension, such as angina or post-MI. *Cardiac output* - **Cardiac output** is a product of **heart rate** and **stroke volume**, and while it directly impacts blood pressure, directly targeting cardiac output as a whole is less common than modulating its individual components or peripheral resistance. - Many antihypertensive drugs reduce cardiac output as a secondary effect of reducing blood volume or heart rate, but directly reducing cardiac output is not the primary mechanism for the most common medications. *Stroke volume* - **Stroke volume** is influenced by **preload**, **afterload**, and **contractility**, and while it impacts cardiac output, it is generally less accessible for direct pharmacological manipulation in hypertension management compared to peripheral resistance. - **Diuretics** can indirectly reduce stroke volume by decreasing preload, but this is often considered a mechanism related to volume status rather than a direct myocardial effect.

Q: The ST Segment of an ECG corresponds to which phase of the action potential?

Plateau phase. ***Plateau phase*** - The **ST segment** of the ECG represents the period when the ventricles are completely depolarized and corresponds to the **plateau phase (phase 2)** of the ventricular myocardial action potential. - During this phase, there is a balance between **calcium influx** and **potassium efflux**, maintaining the depolarized state and contributing to the sustained contraction of the ventricles. *Rapid depolarization* - This phase, represented by the **QRS complex** on the ECG, signifies the rapid influx of sodium ions into the ventricular cells. - It corresponds to **phase 0** of the action potential, where there is a sharp upstroke. *Rapid repolarization* - This corresponds to **phase 3** of the ventricular action potential, where potassium ions rapidly exit the cell, leading to repolarization. - On the ECG, this phase is represented by the **T wave**. *Final repolarization* - This is **not a standard electrophysiological term** in cardiac action potential nomenclature. - The complete repolarization process is represented by the **T wave** (phase 3), which returns the ventricle to its resting potential (phase 4). - The term may cause confusion as it doesn't correspond to a specific phase or ECG component.

Q: Which of the following statements about the oculocardiac reflex is false?

It is mediated by oculomotor and vagus nerve. ***It is mediated by oculomotor and vagus nerve*** - The oculocardiac reflex (OCR) is classically mediated by the **trigeminal nerve (afferent)** and the **vagus nerve (efferent)**, not the oculomotor nerve. - Stimulation of the trigeminal sensory afferents from the eye leads to an efferent vagal response, causing a decrease in heart rate. *It is mediated by trigeminal and vagus nerve.* - This statement accurately describes the neural pathways involved in the oculocardiac reflex, where the **trigeminal nerve acts as the afferent limb** and the **vagus nerve acts as the efferent limb**. - Stimulation of ocular structures activates trigeminal nerve endings, which transmit signals to the brainstem, leading to vagal stimulation and subsequent cardiac effects. *Reflex is more sensitive in neonates* - The oculocardiac reflex is indeed more pronounced and easily triggered in **neonates and young children** due to their relatively immature autonomic nervous system. - This increased sensitivity makes them more susceptible to **bradycardia** during ophthalmic procedures. *It is characterized by bradycardia following traction on extra- ocular muscles* - The classic manifestation of the oculocardiac reflex is **bradycardia** (slowing of the heart rate) in response to stimuli such as pressure on the eyeball or traction on the extraocular muscles. - Other possible manifestations include **arrhythmias**, **asystole**, and hypotension, although bradycardia is the most common.

Q: Inhibition of heart by vagus is mediated by which receptors?

M2. ***M2*** - The **vagus nerve** primarily mediates its inhibitory effects on the heart through **muscarinic M2 receptors**. - Activation of M2 receptors by **acetylcholine** (released from the vagus nerve) decreases heart rate and contractility. *M1* - **M1 receptors** are primarily found in neuronal tissue and glands, playing a role in **gastric acid secretion** and cognitive functions. - They are not the primary muscarinic subclass responsible for vagal inhibition of the heart. *NN* - **NN receptors** are **nicotinic receptors** found on postganglionic neurons in autonomic ganglia. - They are involved in **ganglionic transmission** and are not directly responsible for efferent vagal effects on the heart. *NM* - **NM receptors** are **nicotinic receptors** found at the **neuromuscular junction** of skeletal muscles. - Their activation leads to **skeletal muscle contraction**, and they have no role in regulating heart function.

Q: What is the mechanism by which M2 receptors mediate the inhibition of the heart by the vagus nerve?

Inhibition of adenylate cyclase. ***Inhibition of adenylate cyclase*** - M2 receptors are **Gαi-protein coupled receptors**, and their activation leads to the inhibition of **adenylate cyclase**. - This inhibition reduces the intracellular concentration of **cAMP**, which in turn decreases the activity of **protein kinase A (PKA)**, leading to a decrease in heart rate and contractility. - Additionally, M2 receptors activate **inwardly rectifying potassium channels (IKACh)**, which hyperpolarizes the cell membrane and further slows heart rate. *Activation of phospholipase C* - This mechanism is characteristic of **M1 and M3 muscarinic receptors (Gq-coupled)**, which activate phospholipase C, leading to increased IP3 and DAG. - This pathway is primarily involved in smooth muscle contraction and glandular secretion, not direct cardiac inhibition by M2 receptors. *Inhibition of cAMP breakdown* - Inhibition of **cAMP breakdown** would lead to an increase in cAMP levels, which would stimulate cardiac function. - This effect is mediated by drugs like **phosphodiesterase inhibitors**, which block the enzyme responsible for cAMP degradation, and is opposite to the effect of M2 receptor activation. *Opening of voltage-gated calcium channels* - Opening of voltage-gated calcium channels would **increase** calcium influx, leading to increased contractility and heart rate. - This is the mechanism of action of **sympathetic stimulation via β1-adrenergic receptors**, not parasympathetic M2 receptor activation, which has the opposite effect.

Question 1

Which of the following conditions can lead to a decrease in afterload?

Accepted Answer

Severe anemia

Answer

Hypothyroidism

Answer

Increased physical activity

Answer

None of the options

Question 2

What is the primary role of ion channels in the vascular endothelium?

Accepted Answer

Potassium ion regulation in endothelial cells

Answer

Chloride ion regulation in endothelial cells

Answer

Sodium ion regulation in endothelial cells

Answer

Calcium ion regulation in endothelial cells

Question 3

During the sympathetic fight-or-flight response, what is the primary cardiovascular effect of epinephrine and norepinephrine on skeletal muscle vasculature?

Accepted Answer

Increased blood flow to muscles

Answer

Increased blood flow to the skin

Answer

Bronchoconstriction

Answer

Decreased heart rate

Question 4

Aortic valve closure occurs in which part of cardiac cycle?

Accepted Answer

Beginning of isovolumetric relaxation

Answer

Beginning of isovolumetric contraction

Answer

During rapid ventricular filling

Answer

Beginning of ventricular ejection

Question 5

Which of the following factors is most commonly targeted therapeutically for blood pressure control?

Accepted Answer

Peripheral resistance

Answer

Heart rate

Answer

Cardiac output

Answer

Stroke volume

Question 6

The ST Segment of an ECG corresponds to which phase of the action potential?

Accepted Answer

Plateau phase

Answer

Rapid repolarization

Answer

Final repolarization

Answer

Rapid depolarization

Question 7

Which of the following statements about the oculocardiac reflex is false?

Accepted Answer

It is mediated by oculomotor and vagus nerve

Answer

It is mediated by trigeminal and vagus nerve.

Answer

Reflex is more sensitive in neonates

Answer

It is characterized by bradycardia following traction on extra- ocular muscles

Question 8

Inhibition of heart by vagus is mediated by which receptors?

Accepted Answer

M2

Answer

M1

Answer

NN

Answer

NM

Question 9

What is the mechanism by which M2 receptors mediate the inhibition of the heart by the vagus nerve?

Accepted Answer

Inhibition of adenylate cyclase

Answer

Activation of phospholipase C

Answer

Inhibition of cAMP breakdown

Answer

Opening of voltage-gated calcium channels

Question 10

What is the PRIMARY mechanism by which the Na+-Ca2+ exchanger functions in cardiac muscle cells?

Accepted Answer

Na+-Ca2+ exchanger acts to remove Ca2+ from heart muscle cells

Answer

Na+-Ca2+ exchanger requires ATP directly

Answer

The Na+-Ca2+ exchanger operates in reverse mode during normal cardiac contraction

Answer

The Na+-Ca2+ exchanger primarily moves Ca2+ into cardiac muscle cells during systole

Cardiovascular System — MCQs

Cardiovascular System — MCQs

On this page

Practice by Chapter

Want unlimited practice?